Halozyme Therapeutics, Inc. (HALO)
70.94
-0.59
(-0.82%)
USD |
NASDAQ |
Jun 08, 15:37
Halozyme Therapeutics Total Assets (Quarterly) : 2.673B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 26.48B |
| Agenus, Inc. | 186.46M |
| Altimmune, Inc. | 335.63M |
| Lineage Cell Therapeutics, Inc. | 109.53M |
| Amgen, Inc. | 92.50B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.453B |
| Shareholders Equity (Quarterly) | 219.64M |
| Debt to Equity Ratio | 9.764 |
| Current Ratio | 2.762 |
| Net Debt Paydown Yield | -1.59% |